Saline at lower tonicity in CF (SALTI-CF) trial comparing 0.9% v 3% v 6% nebulised saline.

Tiffany J Dwyer,Mark R Elkins,Ruth Dentice,Samantha Forbes,Peter Cooper,Adam Jaffe,Jennifer Bishop,Peter G Middleton,Peter Wark,Peter T P Bye

The European respiratory journal（2023）

引用 0|浏览1

暂无评分

摘要

Dilution of 6% saline to 3% maintains the benefits for lung function and exacerbation prevention however the positive impacts of 6% saline on quality of life and time to intravenous antibiotics for pulmonary exacerbations are lost.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要